Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

---

Kilickap S., Demirci U., Bugdayci F., Tural D., Korkmaz T., Paydas S., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.14, no.10, 2019 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 14 Issue: 10
• Publication Date: 2019
• Doi Number: 10.1016/j.jtho.2019.08.1166
• Journal Name: JOURNAL OF THORACIC ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Keywords: ALK positive, ROS1 positive, Lorlatinib, Advanced stage lung cancer
• Open Archive Collection: AVESIS Open Access Collection
• Ankara University Affiliated: Yes